CRANBURY, N.J.--(BUSINESS WIRE)--OncLive®, the leading digital provider of resources and information for oncology professionals, announced that clinical cardiologist Dipti Gupta, M.D., M.P.H., and medical oncologist Susan F. Slovin, M.D., Ph.D., will be presenters for the webinar “Androgen Deprivation Therapy in Prostate Cancer and Cardiovascular Risk,” which will take place May 11 at 2 p.m. EDT.
“This webinar offers the perfect opportunity for oncology professionals to hear multidisciplinary experts discuss the advances in hormone therapy, such as androgen deprivation therapy,” said Michael J. Hennessy Jr., president of MJH Associates, Inc., the parent company of OncLive®. “We look forward to hosting this educational webinar to help clinicians transform the lives of patients.”
Webinar topics include the cardioprotective role of androgens, the metabolic changes associated with ADT and the management algorithm for patients on ADT. Featured presenters will also address attendees’ questions about ADT and cardiovascular risks.
“This format helps educate the audience in an interactive setup,” said Robert Goldsmith, vice president of OncLive. “Together with our featured speakers, we will explore best practices and address audience questions in real time.”
To register for the webinar, visit http://www.onclive.com/live-broadcast/androgen-deprivation-therapy.
A digital platform of resources for practicing oncologists, OncLive® offers oncology professionals information they can use to help provide the best patient care. OncLive.com is the official website for MJH Associates’ Oncology Specialty Group, which publishes OncologyLive®, Oncology Nursing News® and more. MJH Associates, Inc., is a full-service health care communications company offering education, research and medical media, including curetoday.com and CURE® magazine, the largest U.S. consumer publication focused entirely on cancer. Combining science and humanity to make cancer understandable, CURE® reaches patients, cancer centers and advocacy groups.